Digest Network Come funziona
Network
/
Società
Te
Non verificato

Telix Pharmaceuticals Limited

Di cosa scriviamo

BancaBiologiaEconomiaFarmaceuticaSanità

29 comunicati stampa

Guarda tutti i comunicati
05/06/2025
Farmaceutica
Sanità
Telix's Illuccix® PSMA-PET Imaging Agent Approved in Germany
Fonte
Telix Pharmaceuticals Limited
Emittente
PR News Wire
1.00
0
04/06/2025
Farmaceutica
Sanità
Telix's Illuccix® PSMA-PET Imaging Agent Approved in Portugal
Fonte
Telix Pharmaceuticals Limited
Emittente
PR News Wire
1.00
0
05/05/2025
Farmaceutica
Sanità
Telix's Illuccix® PSMA-PET Imaging Agent Approved in the Czech Republic
Fonte
Telix Pharmaceuticals Limited
Emittente
PR News Wire
1.00
0
30/04/2025
Farmaceutica
Sanità
Biologia
Illuccix Prostate Cancer PSMA-PET Imaging Agent Approved in Finland
Fonte
Telix Pharmaceuticals Limited
Emittente
PR News Wire
1.00
0
28/04/2025
Farmaceutica
Sanità
Telix's Illuccix PSMA-PET Imaging Agent Approved in France
Fonte
Telix Pharmaceuticals Limited
Emittente
PR News Wire
1.00
0
15/04/2025
Farmaceutica
Sanità
Scienza
Biologia
IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate
Fonte
Telix Pharmaceuticals Limited
Emittente
PR News Wire
1.00
0
15/04/2025
Farmaceutica
Sanità
Illuccix® Prostate Cancer PSMA-PET Imaging Agent Approved in Sweden
Fonte
Telix Pharmaceuticals Limited
Emittente
PR News Wire
1.00
0
17/03/2025
Farmaceutica
Sanità
Biologia
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
Fonte
Telix Pharmaceuticals Limited
Emittente
PR News Wire
1.00
0
12/03/2025
Farmaceutica
Sanità
Biologia
Telix Adds Lead-212 Isotope Production Capability
Fonte
Telix Pharmaceuticals Limited
Emittente
PR News Wire
1.00
0
25/02/2025
Farmaceutica
Sanità
Biologia
Illuccix® Prostate Cancer Imaging Agent Approved in Luxembourg
Fonte
Telix Pharmaceuticals Limited
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0